相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。The Effect of Combined Treatment of Psilocybin and Eugenol on Lipopolysaccharide-Induced Brain Inflammation in Mice
Timur Zanikov et al.
MOLECULES (2023)
Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD
Alan K. Davis et al.
BMJ OPEN (2023)
Dose-related effects of ketamine for antidepressant-resistant symptoms of posttraumatic stress disorder in veterans and active duty military: a double-blind, randomized, placebo-controlled multi-center clinical trial
Chadi G. Abdallah et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Intranasal oxytocin administration impacts the acquisition and consolidation of trauma-associated memories: a double-blind randomized placebo-controlled experimental study in healthy women
Katharina Schultebraucks et al.
NEUROPSYCHOPHARMACOLOGY (2022)
Response to intravenous racemic ketamine after switch from intranasal (S)-ketamine on symptoms of treatment-resistant depression and post-traumatic stress disorder in Veterans: A retrospective case series
Sean Bentley et al.
PHARMACOTHERAPY (2022)
Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disorder
Livia Maria Bolsoni et al.
PSYCHOPHARMACOLOGY (2022)
MiR-153 downregulation alleviates PTSD-like behaviors and reduces cell apoptosis by upregulating the Sigma-1 receptor in the hippocampus of rats exposed to single-prolonged stress
Yu-Lu Chen et al.
EXPERIMENTAL NEUROLOGY (2022)
Post-traumatic stress disorder: clinical and translational neuroscience from cells to circuits
Kerry J. Ressler et al.
NATURE REVIEWS NEUROLOGY (2022)
Childhood Trauma, the HPA Axis and Psychiatric Illnesses: A Targeted Literature Synthesis
Felim Murphy et al.
FRONTIERS IN PSYCHIATRY (2022)
The Multivariate Effect of Ketamine on PTSD: Systematic Review and Meta-Analysis
Rui Du et al.
FRONTIERS IN PSYCHIATRY (2022)
Oxytocin: An Old Hormone, a Novel Psychotropic Drug and its Possible Use in Treating Psychiatric Disorders
Donatella Marazziti et al.
CURRENT MEDICINAL CHEMISTRY (2022)
MicroRNA-124 attenuates PTSD-like behaviors and reduces the level of inflammatory cytokines by downregulating the expression of TRAF6 in the hippocampus of rats following single-prolonged stress
Yao Chen et al.
EXPERIMENTAL NEUROLOGY (2022)
Diverse therapeutic developments for post-traumatic stress disorder (PTSD) indicate common mechanisms of memory modulation
Sanket B. Raut et al.
PHARMACOLOGY & THERAPEUTICS (2022)
Decreased Plasma Oxytocin Levels in Patients With PTSD
Claudia Carmassi et al.
FRONTIERS IN PSYCHOLOGY (2021)
Suicide risk in people with post-traumatic stress disorder: A cohort study of 3.1 million people in Sweden
Verity Fox et al.
JOURNAL OF AFFECTIVE DISORDERS (2021)
Oxytocin and the Neurobiology of Prosocial Behavior
Nina Marsh et al.
NEUROSCIENTIST (2021)
MDMA-assisted psychotherapy for the treatment of PTSD
Collin M. Reiff et al.
BRAZILIAN JOURNAL OF PSYCHIATRY (2021)
The Molecular Biology of Susceptibility to Post-Traumatic Stress Disorder: Highlights of Epigenetics and Epigenomics
Ghazi I. Al Jowf et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Oxytocin in Schizophrenia: Pathophysiology and Implications for Future Treatment
Kah Kheng Goh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Structure, Function, and Pharmacology of Glutamate Receptor Ion Channels
Kasper B. Hansen et al.
PHARMACOLOGICAL REVIEWS (2021)
MicroRNAs as biomarker and novel therapeutic target for posttraumatic stress disorder in Veterans
Sudhiranjan Gupta et al.
PSYCHIATRY RESEARCH (2021)
Effects of intranasal oxytocin on threat- and reward-related functional connectivity in men and women with and without childhood abuse-related PTSD
Lauren M. Sippel et al.
PSYCHIATRY RESEARCH-NEUROIMAGING (2021)
Oxytocin, Neural Plasticity, and Social Behavior
Robert C. Froemke et al.
Annual Review of Neuroscience (2021)
Dysregulation of miR-15a-5p, miR-497a-5p and miR-511-5p Is Associated with Modulation of BDNF and FKBP5 in Brain Areas of PTSD-Related Susceptible and Resilient Mice
Oriana Maria Maurel et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Low-dose clonidine in veterans with Posttraumatic stress disorder
Gregory A. Burek et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2021)
MDMA-assisted therapy for severe PTSD: a randomized, double-blind, placebo-controlled phase 3 study
Jennifer M. Mitchell et al.
NATURE MEDICINE (2021)
The Role of HPA Axis and Allopregnanolone on the Neurobiology of Major Depressive Disorders and PTSD
Felipe Borges Almeida et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Ketamine for post-traumatic stress disorders and it's possible therapeutic mechanism
Muhammad Asim et al.
NEUROCHEMISTRY INTERNATIONAL (2021)
Defining Access and the Role of Community Care in the Veterans Health Administration
A. Taylor Kelley et al.
JOURNAL OF GENERAL INTERNAL MEDICINE (2020)
The role of oxytocin in alcohol and drug abuse
Courtney E. King et al.
BRAIN RESEARCH (2020)
Amygdala Reward Neurons Form and Store Fear Extinction Memory
Xiangyu Zhang et al.
NEURON (2020)
The mediating impact of PTSD symptoms on cortisol awakening response in the context of intimate partner violence
Monica A. Garcia et al.
BIOLOGICAL PSYCHOLOGY (2020)
Protagonist Role of Opioidergic System on Post -Traumatic Stress Disorder and Associated Pain
Marjan Nikbakhtzadeh et al.
PSYCHIATRY INVESTIGATION (2020)
Buprenorphine: prospective novel therapy for depression and PTSD
Caitlin A. Madison et al.
PSYCHOLOGICAL MEDICINE (2020)
Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials
Ana Sofia Vargas et al.
BIOMEDICINES (2020)
The hypothalamic-pituitary-adrenal axis in PTSD: Pathophysiology and treatment interventions
Boadie W. Dunlop et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Members of the same pharmacological family are not alike: Different opioids, different consequences, hope for the opioid crisis?
Michael A. Emery et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Cannabinoid interventions for PTSD: Where to next?
Luke J. Ney et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2019)
Use of Medicinal Cannabis and Synthetic Cannabinoids in Post-Traumatic Stress Disorder (PTSD): A Systematic Review
Laura Orsolini et al.
MEDICINA-LITHUANIA (2019)
Novel pharmacological targets in drug development for the treatment of anxiety and anxiety-related disorders
Simone B. Sartori et al.
PHARMACOLOGY & THERAPEUTICS (2019)
An investigation of the effect of trauma script exposure on risk-taking among patients with substance use disorders and posttraumatic stress disorder
Matthew T. Tull et al.
JOURNAL OF ANXIETY DISORDERS (2019)
Potential of microRNAs as novel targets in the alleviation of pathological fear
C. P. Murphy et al.
GENES BRAIN AND BEHAVIOR (2018)
Longitudinal analyses of the DNA methylome in deployed military servicemen identify susceptibility loci for post-traumatic stress disorder
B. P. F. Rutten et al.
MOLECULAR PSYCHIATRY (2018)
Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of Symptoms of Depression and Suicidality in Patients at Imminent Risk for Suicide: Results of a Double-Blind, Randomized, Placebo-Controlled Study
Carla M. Canuso et al.
AMERICAN JOURNAL OF PSYCHIATRY (2018)
Evidenced-Based Treatment of Posttraumatic Stress Disorder: An Updated Review of Validated Psychotherapeutic and Pharmacological Approaches
Meredith E. Charney et al.
HARVARD REVIEW OF PSYCHIATRY (2018)
Subthreshold PTSD and PTSD in a prospective-longitudinal cohort of military personnel: Potential targets for preventive interventions
David S. Fink et al.
DEPRESSION AND ANXIETY (2018)
Effects of Oxytocin on Working Memory and Executive Control System Connectivity in Posttraumatic Stress Disorder
Julianne C. Flanagan et al.
EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY (2018)
PSD95 and nNOS interaction as a novel molecular target to modulate conditioned fear: relevance to PTSD
L. -P. Li et al.
TRANSLATIONAL PSYCHIATRY (2018)
Cannabidiol as a Therapeutic Alternative for Post-traumatic Stress Disorder: From Bench Research to Confirmation in Human Trials
Rafael M. Bitencourt et al.
FRONTIERS IN NEUROSCIENCE (2018)
Management of nightmares in patients with posttraumatic stress disorder: current perspectives
Ali A. El-Solh
NATURE AND SCIENCE OF SLEEP (2018)
Neuropeptide Y, resilience, and PTSD therapeutics
Marin Kautz et al.
NEUROSCIENCE LETTERS (2017)
Neuroactive steroids and PTSD treatment
Ann M. Rasmusson et al.
NEUROSCIENCE LETTERS (2017)
Synaptic Loss and the Pathophysiology of PTSD: Implications for Ketamine as a Prototype Novel Therapeutic
John H. Krystal et al.
CURRENT PSYCHIATRY REPORTS (2017)
The efficacy of prazosin for the treatment of posttraumatic stress disorder nightmares in US military veterans
Annamarie Breen et al.
JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS (2017)
Nociceptin and the NOP receptor in aversive learning in mice
Abdu Adem et al.
EUROPEAN NEUROPSYCHOPHARMACOLOGY (2017)
Genomewide DNA methylation analysis in combat veterans reveals a novel locus for PTSD
D. Mehta et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Trends in Opioid Use Disorder Diagnoses and Medication Treatment Among Veterans With Posttraumatic Stress Disorder
Brian Shiner et al.
JOURNAL OF DUAL DIAGNOSIS (2017)
Neurobiological Interactions Between Stress and the Endocannabinoid System
Maria Morena et al.
NEUROPSYCHOPHARMACOLOGY (2016)
An Introduction to the Endogenous Cannabinoid System
Hui-Chen Lu et al.
BIOLOGICAL PSYCHIATRY (2016)
Sleep Disturbance in Chronic Military-Related PTSD: Clinical Impact and Response to Adjunctive Risperidone in the Veterans Affairs Cooperative Study #504
John H. Krystal et al.
JOURNAL OF CLINICAL PSYCHIATRY (2016)
The role of Neuropeptide Y in fear conditioning and extinction
R. O. Tasan et al.
NEUROPEPTIDES (2016)
Understanding posttraumatic stress disorder through fear conditioning, extinction and reconsolidation
Mariella Bodemeier Loayza Careaga et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2016)
Psychological Mechanisms of PTSD and Its Treatment
Rebecca K. Sripada et al.
CURRENT PSYCHIATRY REPORTS (2016)
Cannabidiol Regulation of Learned Fear: Implications for Treating Anxiety-Related Disorders
Regimantas Jurkus et al.
FRONTIERS IN PHARMACOLOGY (2016)
PTSD: from neurobiology to pharmacological treatments
Benjamin Kelmendi et al.
EUROPEAN JOURNAL OF PSYCHOTRAUMATOLOGY (2016)
Pharmacotherapy for post-traumatic stress disorder: systematic review and meta-analysis
Mathew Hoskins et al.
BRITISH JOURNAL OF PSYCHIATRY (2015)
Opioid receptors: Structural and mechanistic insights into pharmacology and signaling
Yi Shang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Salivary Oxytocin and Vasopressin Levels in Police Officers With and Without Post-Traumatic Stress Disorder
J. L. Frijling et al.
JOURNAL OF NEUROENDOCRINOLOGY (2015)
Benzodiazepines for PTSD: A Systematic Review and Meta-Analysis
Jeffrey Guina et al.
JOURNAL OF PSYCHIATRIC PRACTICE (2015)
Association of oxytocin level and less severe forms of childhood maltreatment history among healthy Japanese adults involved with child care
Rie Mizuki et al.
FRONTIERS IN BEHAVIORAL NEUROSCIENCE (2015)
Post-traumatic stress disorder
Rachel Yehuda et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Pharmacologic Treatment of Posttraumatic Stress Disorder Among Privately Insured Americans
Ilan Harpaz-Rotem et al.
PSYCHIATRIC SERVICES (2015)
Effect of morphine on the persistence of long-term memory in rats
Gerusa Paz Porto et al.
PSYCHOPHARMACOLOGY (2015)
Oxytocin Pathways and the Evolution of Human Behavior
C. Sue Carter
ANNUAL REVIEW OF PSYCHOLOGY, VOL 65 (2014)
Mental health outcomes in US and UK military personnel returning from Iraq
Josefin Sundin et al.
BRITISH JOURNAL OF PSYCHIATRY (2014)
Early-life stress and HPA axis trigger recurrent adulthood depression
Mario F. Juruena
EPILEPSY & BEHAVIOR (2014)
Anticonvulsants to treat post-traumatic stress disorder
Hee Ryung Wang et al.
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL (2014)
Oxytocin and Autism: A Systematic Review of Randomized Controlled Trials
Antonio Preti et al.
JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY (2014)
Dysregulation in microRNA Expression Is Associated with Alterations in Immune Functions in Combat Veterans with Post-Traumatic Stress Disorder
Juhua Zhou et al.
PLOS ONE (2014)
Intranasal oxytocin as strategy for medication-enhanced psychotherapy of PTSD: Salience processing and fear inhibition processes
Saskia B. J. Koch et al.
PSYCHONEUROENDOCRINOLOGY (2014)
Emotional suppression explains the link between early life stress and plasma oxytocin
Changiz Mohiyeddini et al.
ANXIETY STRESS AND COPING (2014)
MDMA Increases Glutamate Release and Reduces Parvalbumin-Positive GABAergic Cells in the Dorsal Hippocampus of the Rat: Role of Cyclooxygenase
John H. Anneken et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2013)
MicroRNA-182 Regulates Amygdala-Dependent Memory Formation
Erica M. Griggs et al.
JOURNAL OF NEUROSCIENCE (2013)
Plasma Concentrations of Endocannabinoids and Related Primary Fatty Acid Amides in Patients with Post-Traumatic Stress Disorder
Daniela Hauer et al.
PLOS ONE (2013)
Allele-specific epigenetic modification: a molecular mechanism for gene-environment interactions in stress-related psychiatric disorders?
Torsten Klengel et al.
EPIGENOMICS (2013)
Targeting memory processes with drugs to prevent or cure PTSD
Christopher K. Cain et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2012)
Association of Mental Health Disorders With Prescription Opioids and High-Risk Opioid Use in US Veterans of Iraq and Afghanistan
Karen H. Seal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2012)
Molecular and cell signaling targets for PTSD pathophysiology and pharmacotherapy
Richard L. Hauger et al.
NEUROPHARMACOLOGY (2012)
Preclinical Evaluation of Reconsolidation Blockade by Clonidine as a Potential Novel Treatment for Posttraumatic Stress Disorder
Karine Gamache et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Fear conditioning, synaptic plasticity and the amygdala: implications for posttraumatic stress disorder
Amy L. Mahan et al.
TRENDS IN NEUROSCIENCES (2012)
Epigenetic modification of hippocampal Bdnf DNA in adult rats in an animal model of post-traumatic stress disorder
Tania L. Roth et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2011)
Glutamate receptors and signal transduction in learning and memory
Sheng Peng et al.
MOLECULAR BIOLOGY REPORTS (2011)
Persistent anxiolytic affects after chronic administration of the CRF1 receptor antagonist R121919 in rats
David A. Gutman et al.
NEUROPHARMACOLOGY (2011)
A Psychobiological Rationale for Oxytocin in the Treatment of Posttraumatic Stress Disorder
Miranda Olff et al.
CNS SPECTRUMS (2010)
A Study of the Protective Function of Acute Morphine Administration on Subsequent Posttraumatic Stress Disorder
Richard A. Bryant et al.
BIOLOGICAL PSYCHIATRY (2009)
Preliminary Evidence for the Effects of Morphine on Posttraumatic Stress Disorder Symptoms in One- to Four-Year-Olds With Burns
Frederick J. Stoddard et al.
JOURNAL OF BURN CARE & RESEARCH (2009)
Lower CSF oxytocin concentrations in women with a history of childhood abuse
C. Heim et al.
MOLECULAR PSYCHIATRY (2009)
Development of the PTSD-alcohol expectancy questionnaire
Sonya B. Norman et al.
ADDICTIVE BEHAVIORS (2008)
Divalproex in the treatment of posttraumatic stress disorder - A randomized, double-blind, placebo-controlled trial in a veteran population
Lori L. Davis et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2008)
Amygdala intercalated neurons are required for expression of fear extinction
Ekaterina Likhtik et al.
NATURE (2008)
High-affinity CRF1 receptor antagonist NBI-34041:: Preclinical and clinical data suggest safety and efficacy in attenuating elevated stress response
Marcus Ising et al.
NEUROPSYCHOPHARMACOLOGY (2007)
A placebo-controlled trial of bupropion SR in the treatment of chronic posttraumatic stress disorder
Mary E. Becker et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
Open-label trial of escitalopram in the treatment of posttraumatic stress disorder
Sophie Robert et al.
JOURNAL OF CLINICAL PSYCHIATRY (2006)
Historical approaches to post-combat disorders
E Jones
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2006)
SSRIs versus non-SSRIs in post-traumatic stress disorder - An update with recommendations
GM Asnis et al.
DRUGS (2004)
Comparison of nefazodone and sertraline for the treatment of posttraumatic stress disorder
AL McRae et al.
DEPRESSION AND ANXIETY (2004)
Systemic oxytocin treatment modulates glucocorticoid and mineralocorticoid receptor mRNA in the rat hippocampus
M Petersson et al.
NEUROSCIENCE LETTERS (2003)
Early historical literature for post-traumatic symptomatology
P Birmes et al.
STRESS AND HEALTH (2003)
Reduction of nightmares and other PTSD symptoms in combat veterans by prazosin:: A placebo-controlled study
MA Raskind et al.
AMERICAN JOURNAL OF PSYCHIATRY (2003)
Beyond the role of glutamate as a neurotransmitter
M Nedergaard et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Prazosin reduces nightmares in combat veterans with posttraumatic stress disorder
MA Raskind et al.
JOURNAL OF CLINICAL PSYCHIATRY (2002)
Relationship between acute morphine and the course of PTSD in children with burns
G Saxe et al.
JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY (2001)
Meta-analysis of risk factors for posttraumatic stress disorder in trauma-exposed adults
CR Brewin et al.
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY (2000)